Question:
>I never heard of it until a few minutes ago. I don’t understand the product >or the approach.
[snip] Thanks for the link. Oral Hectorol definitely belongs on my Vitamin-D Analogs page, even though it appears to be an analog of vitamin D2 instead of D3. http://psorsite.com/calcipo.html It’ll probably be a competitor with Dovonex, if the testing pans out. Judging by the other drugs listed on Bone Care’s chart, I wouldn’t expect this one to hit the streets as approved for psoriasis until at least 2005. – Dave W. http://psorsite.com/
Response:
I never heard of it until a few minutes ago. I don’t understand the product or the approach. "Bone Care (www.bonecare.com) is a pharmaceutical company engaged in discovering, developing and commercializing improved vitamin D-hormone therapies to treat secondary hyperparathyroidism in patients with kidney, or renal disease, and osteoporosis, and other diseases including psoriasis and cancers of the prostate, breast and colon." Note ‘Psoriasis’ at the bottom of the chart here: http://www.bonecare.com/company/product_pipeline.html
Response:
>I never heard of it until a few minutes ago. I don’t understand the product >or the approach. >"Bone Care (www.bonecare.com) is a pharmaceutical company engaged in >discovering, developing and commercializing improved vitamin D-hormone >therapies to treat secondary hyperparathyroidism in patients with kidney, or >renal disease, and osteoporosis, and other diseases including psoriasis and >cancers of the prostate, breast and colon."
Well, Dovonex is a vitamin-D derivative, so maybe they’re working on something along those lines. J.